Pain Medicine, Interventional Pain Medicine · Durham, NC
NPI
1720263239
Since 2008
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
5322 Highgate Dr Ste 143
Durham, NC, 27713
Phone (984) 464-7972
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
2,102 services
Medicare patients, 2024
119
Average age 70
Drug cost, 2024
$454K
3,359 prescriptions
Company payments, 2025
$89.1
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Manoj B Wunnava was code 99214 (office e&m - established), 565 times for 102 patients. In total Manoj B Wunnava billed 2,102 services in 34 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 565 | 102 | $89.60 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 340 | 83 | $12.30 | $4,181 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 228 | 37 | $0.75 | $170 |
| 99215 Office E&M - Established | Office | 150 | 50 | $132.04 | $20K |
| 80305 Drug Tests | Office | 71 | 71 | $12.06 | $856 |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 49 | 15 | $0.26 | $12.73 |
| 99205 Office E&M - New | Office | 25 | 25 | $159.14 | $3,978 |
| 62323 Nerve Block Injection - Back | Office | 14 | 13 | $169.67 | $2,375 |
By year: 2022 $88K for 2,407 services; 2023 $93K for 2,442 services; 2024 $107K for 2,102 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 71 | 71 | $12.06 | $856 |
Medicare prescription drug claims, 2024
In 2024, the drug Manoj B Wunnava prescribed most often to Medicare patients was Oxycodone Hcl, with 391 prescriptions and refills. In total Manoj B Wunnava wrote 3,359 Medicare prescriptions that cost $454K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 391 | 392 | 50 | $8,918 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 290 | 290 | 35 | $8,476 |
| Gabapentin Generic | 257 | 401 | 58 | $4,794 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 223 | 223 | 24 | $8,035 |
| Pregabalin Generic | 193 | 227 | 35 | $2,907 |
| Tramadol Hcl Generic | 177 | 182 | 30 | $1,782 |
| Duloxetine Hcl Generic | 167 | 253 | 29 | $3,312 |
| Buprenorphine Generic | 159 | 159 | 41 | $30K |
| Methadone Hcl Generic | 130 | 130 | 14 | $3,421 |
| Morphine Sulfate Er Morphine Sulfate | 122 | 122 | 16 | $3,464 |
| Tizanidine Hcl Generic | 81 | 98 | 21 | $522 |
| Movantik Naloxegol Oxalate | 66 | 77 | 15 | $30K |
| Baclofen Generic | 61 | 73 | 14 | $591 |
| Oxycontin Oxycodone Hcl | 58 | 58 | Under 11 | $56K |
| Hydromorphone Hcl Generic | 53 | 53 | Under 11 | $548 |
Brand drugs: 335 claims; generic drugs: 3,024 claims; opioid claims: 1,792.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manoj B Wunnava $89.1 ($89.1 in general payments such as food, travel and fees) from 3 companies. The largest payer was Virtus Pharmaceuticals LLC with $58.81.
| Company | Payments | Amount |
|---|---|---|
| Virtus Pharmaceuticals LLC | 3 | $58.81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $15.46 |
| Valinor Pharma, LLC | 1 | $14.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.